These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8923076
1. The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide. al-Alaiyan S, al-Omran A, Dyer D. Intensive Care Med; 1996 Oct; 22(10):1093-5. PubMed ID: 8923076 [Abstract] [Full Text] [Related]
2. The use of L-arginine [correction of F-arginine] and phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide. Saidy K, al-Alaiyan S. Indian J Pediatr; 2001 Feb; 68(2):175-7. PubMed ID: 11284188 [Abstract] [Full Text] [Related]
8. Long-term inhaled nitric oxide plus dipyridamole for pulmonary arterial hypertension. Pérez-Peñate G, Cabrera Navarro P, Ponce González M, Górriz Gómez E, Pulido Duque J, García Quintana A, Juliá Serdá G. Respiration; 2005 Dec; 72(4):419-22. PubMed ID: 16088287 [Abstract] [Full Text] [Related]
9. Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults. Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A. Int J Cardiol; 2005 Aug 18; 103(2):156-63. PubMed ID: 16080974 [Abstract] [Full Text] [Related]
12. Inhaled nitric oxide in the management of persistent pulmonary hypertension of term infants. Chen JY, Su PH, Chen FL, Lee HS. J Formos Med Assoc; 2001 Oct 18; 100(10):703-6. PubMed ID: 11760378 [Abstract] [Full Text] [Related]
13. Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. Travadi JN, Patole SK. Pediatr Pulmonol; 2003 Dec 18; 36(6):529-35. PubMed ID: 14618646 [Abstract] [Full Text] [Related]
15. [TREATMENT WITH INO OF INFANTS WITH PPHN.]. Radulova P, Vakrilova L, Slancheva B, Marinov R, Zlatkov V. Akush Ginekol (Sofiia); 2016 Dec 18; 55(4):58-64. PubMed ID: 29370497 [Abstract] [Full Text] [Related]
16. Current and future therapeutic options for persistent pulmonary hypertension in the newborn. Rao S, Bartle D, Patole S. Expert Rev Cardiovasc Ther; 2010 Jun 18; 8(6):845-62. PubMed ID: 20528642 [Abstract] [Full Text] [Related]
17. Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide and prostacyclin, responsive to neuromuscular blockade. Filippi L, Serafini L, Gozzini E, Poggi C, Moroni M, Fiorini P. Minerva Pediatr; 2011 Jun 18; 63(3):233-5. PubMed ID: 21654603 [Abstract] [Full Text] [Related]